Amniotic Fluid Embolism After Cervical Ripening
- PMID: 39759675
- PMCID: PMC11700476
- DOI: 10.7759/cureus.75212
Amniotic Fluid Embolism After Cervical Ripening
Abstract
Amniotic fluid embolism (AFE) is a rare condition that can have catastrophic maternal and infant consequences. It can lead to rapid multisystem failure and is responsible for a significant portion of maternal deaths. The diagnosis is frequently made late in the pathological process, and the treatment is mainly supportive and infant delivery. It cannot be prevented. Whether cervical ripening and labor induction are risk factors is controversial. A 31-year-old woman who was undergoing cervical ripening and induction of labor at 38 weeks gestation for medication-controlled gestational diabetes (A2GDM) was admitted for delivery. She received five doses of 25 µg vaginal misoprostol serially and, ultimately, a Foley catheter cervical balloon. After approximately 24 hours, she had the sudden onset of unexpected persistent fetal bradycardia. Her cervix was 4 cm at the time of the fetal distress. When she arrived in the operating room, she was hypoxic and difficult to awaken. An emergency cesarean delivery was performed under general endotracheal anesthesia. Immediately after the delivery of a profoundly depressed and acidotic infant with an umbilical cord pH of 6.84, she became hypotensive, requiring vasopressors. After diffuse intravascular coagulation was diagnosed, treatment for AFE was implemented. AFE has a high mortality rate, and the length of time needed to identify the condition and the availability of specialty resources are two elements that can affect the outcome. Newer alternative treatments, such as the supportive "A-OK" (atropine, ondansetron, and ketorolac administration) protocol for AFE, are discussed. Ultimately, both mother and baby survived and, at the six-month check, are doing well with no sequelae.
Keywords: amniotic fluid embolism pathophysiology; amniotic fluid embolism treatment; cesarean birth; fetal outcome; pre-induction cervical ripening.
Copyright © 2024, French et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Six vs 12 hours of Foley catheter balloon placement in the labor induction of multiparas with unfavorable cervixes: a randomized controlled trial.Am J Obstet Gynecol MFM. 2023 Nov;5(11):101142. doi: 10.1016/j.ajogmf.2023.101142. Epub 2023 Aug 27. Am J Obstet Gynecol MFM. 2023. PMID: 37643690 Clinical Trial.
-
Evaluation of mechanical and nonmechanical methods of cervix ripening in women with pre-labor rupture of membranes: a randomized controlled trial.Am J Obstet Gynecol MFM. 2023 Apr;5(4):100868. doi: 10.1016/j.ajogmf.2023.100868. Epub 2023 Jan 20. Am J Obstet Gynecol MFM. 2023. PMID: 36690182 Clinical Trial.
-
Six compared with 12 hours of Foley balloon placement for labor induction in nulliparous women with unripe cervices: a randomized controlled trial.Am J Obstet Gynecol MFM. 2023 Nov;5(11):101157. doi: 10.1016/j.ajogmf.2023.101157. Epub 2023 Sep 17. Am J Obstet Gynecol MFM. 2023. PMID: 37722505 Clinical Trial.
-
Early vs. delayed amniotomy in individuals undergoing pre-induction cervical ripening with transcervical Foley balloon: a meta-analysis.Am J Obstet Gynecol MFM. 2024 Aug;6(8):101408. doi: 10.1016/j.ajogmf.2024.101408. Epub 2024 Jun 17. Am J Obstet Gynecol MFM. 2024. PMID: 38897352
-
Amniotic fluid embolism.J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):153-9. doi: 10.4103/0970-9185.173356. J Anaesthesiol Clin Pharmacol. 2016. PMID: 27275041 Free PMC article. Review.
References
-
- Anaphylactoid syndrome of pregnancy: a review of the literature with latest management and outcome data. Gilmore DA, Wakim J, Secrest J, Rawson R. http://pubmed.ncbi.nlm.nih.gov/12776640/ AANA J. 2003;71:120–126. - PubMed
-
- Pregnancy-related mortality in the United States, 1998 to 2005. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Obstet Gynecol. 2010;116:1302–1309. - PubMed
-
- Amniotic fluid embolism: update and review. Sultan P, Seligman K, Carvalho B. Curr Opin Anaesthesiol. 2016;29:288–296. - PubMed
-
- Amniotic fluid embolism: diagnosis and management. Pacheco LD, Saade G, Hankins GD, Clark SL. Am J Obstet Gynecol. 2016;215:16–24. - PubMed
Publication types
LinkOut - more resources
Full Text Sources